SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-071560
Filing Date
2022-11-14
Accepted
2022-11-14 07:15:12
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168508-8k_gamidacell.htm   iXBRL 8-K 30326
2 PRESS RELEASE, DATED NOVEMBER 14, 2022 ea168508ex99-1_gamidacell.htm EX-99.1 225823
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2506
  Complete submission text file 0001213900-22-071560.txt   453690

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE gmda-20221114_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE gmda-20221114_pre.xml EX-101.PRE 22365
6 XBRL SCHEMA FILE gmda-20221114.xsd EX-101.SCH 3236
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168508-8k_gamidacell_htm.xml XML 3621
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 221380165
SIC: 2836 Biological Products, (No Diagnostic Substances)